Odyssey Health (ODYY) Net Income towards Common Stockholders (2014 - 2026)
Odyssey Health (ODYY) posted Net Income towards Common Stockholders of $765890.0 for Q2 2026, up 228.86% on a QoQ basis from -$594371.0 in Q1 2026, and up 404.23% year-over-year from $151891.5 in Q2 2025.
Powered by 
Analysis
Odyssey Health (ODYY) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
Odyssey Health has reported Net Income towards Common Stockholders for 13 years, with the latest figure at $765890.0 in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 404.23% year-over-year to $765890.0 in Q2 2026; TTM through Apr 2026 was -$478923.0, a 96.54% increase from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 92.4% from the prior year.
- Net Income towards Common Stockholders was $765890.0 for Q2 2026 at Odyssey Health, up from -$594371.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $13.2 million in Q1 2024, with the low at -$12.7 million in Q3 2024.
- Average Net Income towards Common Stockholders over 5 years is -$873351.4, with a median of -$731108.5 recorded in 2023.
- The largest YoY upside for Net Income towards Common Stockholders was 890.45% in 2024 against a maximum downside of 1465.03% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at -$2.1 million in 2022, then jumped by 74.96% to -$538100.0 in 2023, then dropped by 20.46% to -$648208.0 in 2024, then jumped by 38.52% to -$398526.0 in 2025, then surged by 292.18% to $765890.0 in 2026.
- The last three Net Income towards Common Stockholders figures came in at $765890.0 (Q2 2026), -$594371.0 (Q1 2026), and -$398526.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 178.50 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 124.21 Bn | 118.99 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.39 Bn | 65.86 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | 765,890.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 765,890.00 |
| Jan 31, 2026 | -594,371.00 |
| Oct 31, 2025 | -398,526.00 |
| Jul 31, 2025 | -251,916.00 |
| Apr 30, 2025 | -251,743.00 |
| Jan 31, 2025 | -220,126.00 |
| Oct 31, 2024 | -648,208.00 |
| Jul 31, 2024 | -12.74 Mn |
| Apr 30, 2024 | -842,341.00 |
| Jan 31, 2024 | 13.21 Mn |
| Oct 31, 2023 | -538,100.00 |
| Jul 31, 2023 | -814,009.00 |
| Apr 30, 2023 | -1.28 Mn |
| Jan 31, 2023 | -1.67 Mn |
| Oct 31, 2022 | -2.15 Mn |
| Jul 31, 2022 | -2.01 Mn |
| Apr 30, 2022 | -3.10 Mn |
| Jan 31, 2022 | -2.18 Mn |
| Oct 31, 2021 | -1.65 Mn |
| Jul 31, 2021 | -2.90 Mn |